Search results
FDA vaccine advisers vote unanimously in favor of updated COVID-19 shot for fall
WPTZ Burlington· 2 days agoThe Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to...
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 5 days agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 12 hours agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 5 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented ...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 3 days agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 3 days agoVaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were prepared to make...
The FDA tells COVID-19 vaccine makers to update shot to target newest variant
KSL TV Utah· 8 hours agoThe FDA told the advisory committee Wednesday that studies have shown that the currently available...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CBS 58 Milwaukee· 10 hours agoThe FDA told the advisory committee Wednesday that studies have shown that the currently available Covid-19 vaccines appear to be less effective against ...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 2 days agovaccines have the advantage of being able to be quickly designed and produced, as mRNA molecules are...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 4 days agoBy then, researchers had realized the most effective near-term use of a vaccine was probably to stop...